Vertex Pharmaceuticals (BER:VX1) Price Target Increased by 10.91% to 341.78
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
The average one-year price target for Vertex Pharmaceuticals (BER:VX1) has been revised to 341.78 / share. This is an increase of 10.91% from the prior estimate of 308.16 dated April 6, 2023. The price target is an average of many targets provided by analysts.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-931502252-a77507c63d7a4fd0a40757acd8c61bd8.jpg "Calculating the Payback Period With Excel")
:max_bytes(150000):strip_icc():format(jpeg)/how-to-get-dental-implants-covered-by-insurance-8580639-final-32bfbed60ccd4b7d9bd779c178672de5.png "How to Get Dental Implants Covered by Insurance")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1690944060-bfe2f518300d485e8962d425003e5c56.jpg "Ray Dalio Reveals How His Costliest Blunder Turned Into His Best Investing Lesson")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1737291285-9d716e771ad849e1b7938a09f8b1a94e.jpg "How to Find the Best Mortgage Rates")